Insmed Inc INSM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:51 PM EDT
29.71quote price arrow down-0.35 (-1.16%)
Volume
859,438
52 week range
23.95 - 45.44

...

Loading . . .
  • Open30.28
  • Day High30.74
  • Day Low29.71
  • Prev Close30.06
  • 52 Week High45.44
  • 52 Week High Date02/09/21
  • 52 Week Low23.95
  • 52 Week Low Date05/26/21

Key Stats

  • Market Cap3.366B
  • Shares Out113.28M
  • 10 Day Average Volume0.95M
  • Dividend-
  • Dividend Yield-
  • Beta2.25
  • YTD % Change-9.19

KEY STATS

  • Open30.28
  • Day High30.74
  • Day Low29.71
  • Prev Close30.06
  • 52 Week High45.44
  • 52 Week High Date02/09/21
  • 52 Week Low23.95
  • 52 Week Low Date05/26/21
  • Market Cap3.366B
  • Shares Out113.28M
  • 10 Day Average Volume0.95M
  • Dividend-
  • Dividend Yield-
  • Beta2.25
  • YTD % Change-9.19

RATIOS/PROFITABILITY

  • EPS (TTM)-3.15
  • P/E (TTM)-9.42
  • Fwd P/E (NTM)-10.02
  • EBITDA (MRQ)-273.434M
  • ROE (MRQ)-156.42%
  • Revenue (MRQ)167.77M
  • Gross Margin (MRQ)75.40%
  • Net Margin (MRQ)-190.36%
  • Debt To Equity (MRQ)187.03%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Insmed Inc

There is no recent news for this security.

Profile

MORE
Insmed Incorporated is a global biopharmaceutical company. The Company’s product ARIKAYCE (amikacin liposome inhalation suspension) is developed for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The Company's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic...
William Lewis
Chairman
Roger Adsett
Chief Operating Officer
Sara Bonstein
Chief Financial Officer
Address
700 US Highway 202/206
Bridgewater, NJ
08807-1704
United States

Top Peers

SYMBOLLASTCHG%CHG
DRNA
Dicerna Pharmaceuticals Inc
37.74+0.38+1.02%
NKTR
Nektar Therapeutics
18.01+0.40+2.27%
RLAY
Relay Therapeutics Inc
34.46+0.24+0.70%
GBT
Global Blood Therapeutics Inc
40.42-0.21-0.53%
VCEL
Vericel Corp
57.80+0.22+0.38%